Presentation is loading. Please wait.

Presentation is loading. Please wait.

498. Prolonged Benefit from Systemic rAAV8 in a Canine Model of Myotubular Myopathy  Matthew Elverman, David Mack, Melissa Goddard, Jessica Snyder, Robert.

Published byMinka Kraigher Modified over 6 years ago

Similar presentations

Presentation on theme: "498. Prolonged Benefit from Systemic rAAV8 in a Canine Model of Myotubular Myopathy  Matthew Elverman, David Mack, Melissa Goddard, Jessica Snyder, Robert."— Presentation transcript:

1 498. Prolonged Benefit from Systemic rAAV8 in a Canine Model of Myotubular Myopathy 
Matthew Elverman, David Mack, Melissa Goddard, Jessica Snyder, Robert Grange, Karine Poulard, Virginie Latournerie, Philippe Veron, Laurine Buscara, Christine Le Bec, Samia Martin, Fulvio Mavilio, Federico Mingozzi, Hui Meng, Michael Lawlor, Alan Beggs, Anna Buj- Bello, Martin Childers  Molecular Therapy  Volume 24, (May 2016) DOI: /S (16)33307-X Copyright © 2016 The American Society of Gene & Cell Therapy Terms and Conditions

2 Molecular Therapy 2016 24, DOI: (10.1016/S1525-0016(16)33307-X)
Copyright © 2016 The American Society of Gene & Cell Therapy Terms and Conditions

Download ppt "498. Prolonged Benefit from Systemic rAAV8 in a Canine Model of Myotubular Myopathy  Matthew Elverman, David Mack, Melissa Goddard, Jessica Snyder, Robert."

Similar presentations

Jennifer G. Cheung, Krystyna Konopka, Nejat Düzgünes

Jennifer G. Cheung, Krystyna Konopka, Nejat Düzgünes
Volume 20, Issue 2, (February 2012)

Volume 20, Issue 2, (February 2012)
414. A Novel Clinical Severity Scoring Measure in Canine X-Linked Myotubular Myopathy: Results Following Systemic AAV Gene Replacement    Molecular Therapy 

414. A Novel Clinical Severity Scoring Measure in Canine X-Linked Myotubular Myopathy: Results Following Systemic AAV Gene Replacement    Molecular Therapy 
209. Use of Helicobacter pyroli Neutrophil Activating Protein (NAP) as an Immune- Modulatory Agent To Enhance the Efficacy of Oncolytic Adenovirus Therapy.

209. Use of Helicobacter pyroli Neutrophil Activating Protein (NAP) as an Immune- Modulatory Agent To Enhance the Efficacy of Oncolytic Adenovirus Therapy.
Volume 25, Issue 4, Pages (April 2017)

Volume 25, Issue 4, Pages (April 2017)
446. Gender Differences in the Osteogenic & Chondrogenic Potential of Human Muscle- Derived Stem Cells In Vitro  Alex C. Scibetta, Andrea B. Liebowitz,

446. Gender Differences in the Osteogenic & Chondrogenic Potential of Human Muscle- Derived Stem Cells In Vitro  Alex C. Scibetta, Andrea B. Liebowitz,
Man's Best Friend: Utilizing Naturally Occurring Tumors in Dogs to Improve Chimeric Antigen Receptor T-cell Therapy for Human Cancers  Melinda Mata, Stephen.

Man's Best Friend: Utilizing Naturally Occurring Tumors in Dogs to Improve Chimeric Antigen Receptor T-cell Therapy for Human Cancers  Melinda Mata, Stephen.
Genome-editing Technologies for Gene and Cell Therapy

Genome-editing Technologies for Gene and Cell Therapy
627. Non-Invasive, Multimodal Imaging of Microvesicles with Metabolically Biotinylated, Membrane-Bound Gaussia Luciferase    Molecular Therapy  Volume.

627. Non-Invasive, Multimodal Imaging of Microvesicles with Metabolically Biotinylated, Membrane-Bound Gaussia Luciferase    Molecular Therapy  Volume.
Elizabeth Morris, Alex Scibetta, Aiping Lu, Xueqin Gao, Johnny Huard

Elizabeth Morris, Alex Scibetta, Aiping Lu, Xueqin Gao, Johnny Huard
162. Stability of Polymer/Plasmid DNA Complexes In Vitro and In Vivo

162. Stability of Polymer/Plasmid DNA Complexes In Vitro and In Vivo
281. Rapid Generation of Induced Pluripotent Stem Cells (iPSCs) from the Urine of a Patient with Duchenne Muscular Dystrophy    Molecular Therapy  Volume.

281. Rapid Generation of Induced Pluripotent Stem Cells (iPSCs) from the Urine of a Patient with Duchenne Muscular Dystrophy    Molecular Therapy  Volume.
Direct Conversion of Skin Cells into Blood: Alchemy or Science?

Direct Conversion of Skin Cells into Blood: Alchemy or Science?
Molecular Therapy  Volume 20, Pages S261-S262 (May 2012) DOI: /S (16)

Molecular Therapy  Volume 20, Pages S261-S262 (May 2012) DOI: /S (16)
Evolving Gene Therapy in Primary Immunodeficiency

Evolving Gene Therapy in Primary Immunodeficiency
343. Benchtop DNA Synthesizer: Oligo-Templated Polymerization (OTP)

343. Benchtop DNA Synthesizer: Oligo-Templated Polymerization (OTP)
In This Issue Cell Volume 158, Issue 5, (August 2014)

In This Issue Cell Volume 158, Issue 5, (August 2014)
152. The Effects of AdVEGF-B and AdVEGF-D on Angiogenesis and Arteriogenesis in a Novel Porcine Model of Percutaneous Bottleneck Stent Induced Chronic.

152. The Effects of AdVEGF-B and AdVEGF-D on Angiogenesis and Arteriogenesis in a Novel Porcine Model of Percutaneous Bottleneck Stent Induced Chronic.
637. Effect of PEG Grafting Degree on Morphology and Transfection Efficiency of Polycation-g-PEG/DNA Nanoparticles    Molecular Therapy  Volume 20, (May.

637. Effect of PEG Grafting Degree on Morphology and Transfection Efficiency of Polycation-g-PEG/DNA Nanoparticles    Molecular Therapy  Volume 20, (May.
Escaping the Valley of Death

Escaping the Valley of Death

Similar presentations

Ads by Google